<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101465400</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34171</journal-id>
<journal-id journal-id-type="nlm-ta">Sci Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Signal</journal-id>
<journal-title-group>
<journal-title>Science signaling</journal-title>
</journal-title-group>
<issn pub-type="ppub">1945-0877</issn>
<issn pub-type="epub">1937-9145</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29114037</article-id>
<article-id pub-id-type="pmc">5858943</article-id>
<article-id pub-id-type="doi">10.1126/scisignal.aan0665</article-id>
<article-id pub-id-type="manuscript">NIHMS949488</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reducing eIF4E-eIF4G Interactions Restores the Balance Between Protein Synthesis and Actin Dynamics in Fragile X Syndrome Model Mice<sup><xref ref-type="fn" rid="FN5">*</xref></sup></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Santini</surname>
<given-names>Emanuela</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huynh</surname>
<given-names>Thu N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN4">†</xref>
<xref ref-type="author-notes" rid="FN3">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Longo</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN4">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koo</surname>
<given-names>So Yeon</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mojica</surname>
<given-names>Edward</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Andrea</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bagni</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klann</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">°</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Center for Neural Science, New York University, New York, NY 10003</aff>
<aff id="A2">
<label>2</label>Department of Neurology, Columbia University, New York, NY 10032</aff>
<aff id="A3">
<label>3</label>Center for Human Genetics and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, 3000 Leuven, Belgium</aff>
<aff id="A4">
<label>4</label>VIB Center for the Biology of Disease, 3000 Leuven, Belgium</aff>
<aff id="A5">
<label>5</label>Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, 00133 Rome, Italy</aff>
<aff id="A6">
<label>6</label>Department of Fundamental Neuroscience, University of Lausanne, 1005 Lausanne, Switzerland</aff>
<author-notes>
<corresp id="FN1"><label>°</label>Corresponding author. <email>eklann@cns.nyu.edu</email></corresp>
<fn fn-type="present-address" id="FN2">
<label>*</label>
<p>Current address: Department of Neurology, Columbia University, New York, NY 10032.</p>
</fn>
<fn fn-type="present-address" id="FN3">
<label>**</label>
<p>Current address: Brain and Mind Research Institute; Department of Psychiatry, Weill Cornell Medical College, New York, NY 10065.</p>
</fn>
<fn fn-type="equal" id="FN4">
<label>†</label>
<p>Authors contributed equally.</p>
</fn>
<fn fn-type="COI-statement" id="FN6">
<p><bold>Competing interests:</bold> The authors declare that they have no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<day>07</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>10</volume>
<issue>504</issue>
<elocation-id>eaan0665</elocation-id>
<abstract>
<p id="P1">Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and autism spectrum disorder. FXS is caused by silencing of the <italic>FMR1</italic> gene, which encodes fragile X mental retardation protein (FMRP), an mRNA-binding protein that represses the translation of its target mRNAs. One mechanism by which FMRP represses translation is through its association with cytoplasmic FMRP-interacting protein 1 (CYFIP1), which binds to and sequesters eukaryotic initiation factor 4E (eIF4E). CYFIP1 shuttles between the FMRP–eIF4E complex and the Rac1–Wave regulatory complex, thereby connecting translation regulation to actin dynamics and dendritic spine morphology, which are dysregulated in FXS model mice that lack FMRP. Treating FXS mice with 4EGI-1, which blocks interactions between eIF4E and eukaryotic factor 4G (eIF4G), a critical interacting partner for protein synthesis, reversed defects in hippocampus-dependent memory and spine morphology. We also found that 4EGI-1 normalized the phenotypes of enhanced metabotropic glutamate receptor (mGluR)-mediated long-term depression (LTD), upregulated Rac1–p21-activated kinase (PAK)–cofilin signaling, altered actin dynamics, and dysregulated CYFIP1/eIF4E and CYFIP1/Rac1 interactions in FXS mice. Our findings are consistent with the idea that an imbalance of protein synthesis and actin dynamics contributes to pathophysiology in FXS mice, and suggest that targeting eIF4E may be a strategy for treating FXS.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>